Total Payments
$5,174
2024 Payments
$1,725
Companies
31
Transactions
267
Medicare Patients
1,926
Medicare Billing
$372,441
Payment Breakdown by Category
Food & Beverage$5,024 (97.1%)
Consulting$150.00 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,024 | 266 | 97.1% |
| Consulting Fee | $150.00 | 1 | 2.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $856.02 | 37 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $669.28 | 39 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $562.47 | 35 | $0 (2024) |
| Alkermes, Inc. | $407.83 | 13 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $350.78 | 23 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $278.14 | 15 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $227.98 | 12 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $226.32 | 11 | $0 (2024) |
| Lundbeck LLC | $163.50 | 8 | $0 (2024) |
| Tris Pharma Inc | $160.47 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,725 | 80 | ABBVIE INC. ($400.61) |
| 2023 | $984.72 | 51 | ABBVIE INC. ($197.69) |
| 2022 | $624.55 | 29 | ABBVIE INC. ($214.66) |
| 2021 | $222.95 | 9 | Teva Pharmaceuticals USA, Inc. ($155.02) |
| 2020 | $281.67 | 16 | Sunovion Pharmaceuticals Inc. ($80.59) |
| 2019 | $820.32 | 57 | Neurocrine Biosciences, Inc. ($164.17) |
| 2018 | $260.78 | 18 | Otsuka America Pharmaceutical, Inc. ($77.44) |
| 2017 | $254.18 | 7 | Alkermes, Inc. ($150.00) |
All Payment Transactions
267 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.42 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $15.82 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Central Nervous System | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Central Nervous System | ||||||
| 12/03/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: ADHD | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Neuroscience | ||||||
| 10/31/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: CNS | ||||||
| 10/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: Neuropsychiatry | ||||||
| 10/24/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/03/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Neurology | ||||||
| 09/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.68 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Central Nervous System | ||||||
| 08/28/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.72 | General |
| Category: PSYCHIATRY | ||||||
| 08/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: Neuropsychiatry | ||||||
| 08/13/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 08/07/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: ANTI-ANXIETY | ||||||
| 08/06/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 375 | 1,074 | $153,775 | $72,946 |
| 2022 | 7 | 495 | 1,623 | $240,800 | $104,891 |
| 2021 | 5 | 511 | 1,576 | $228,860 | $100,326 |
| 2020 | 5 | 545 | 1,545 | $226,390 | $94,278 |
Total Patients
1,926
Total Services
5,818
Medicare Billing
$372,441
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 128 | 518 | $72,520 | $32,170 | 44.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 102 | 379 | $47,375 | $25,030 | 52.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 71 | 78 | $16,380 | $7,452 | 45.5% |
| 90870 | Therapy using electrical currents | Facility | 2023 | 13 | 36 | $6,840 | $2,988 | 43.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 38 | 40 | $5,200 | $2,543 | 48.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 11 | 11 | $3,300 | $1,679 | 50.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 12 | 12 | $2,160 | $1,085 | 50.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 188 | 998 | $139,720 | $55,615 | 39.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 296 | $37,000 | $19,370 | 52.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 135 | 159 | $33,390 | $15,989 | 47.9% |
| 90870 | Therapy using electrical currents | Facility | 2022 | 17 | 59 | $11,210 | $4,997 | 44.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 44 | 50 | $9,000 | $4,064 | 45.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 43 | 46 | $5,980 | $2,606 | 43.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 15 | 15 | $4,500 | $2,249 | 50.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 217 | 1,000 | $140,000 | $56,383 | 40.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 320 | $40,000 | $20,134 | 50.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 143 | 161 | $33,810 | $16,875 | 49.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 50 | 54 | $9,720 | $4,570 | 47.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 40 | 41 | $5,330 | $2,365 | 44.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 228 | 934 | $130,760 | $51,851 | 39.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 144 | 169 | $35,490 | $17,924 | 50.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 64 | 324 | $40,500 | $15,620 | 38.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 77 | 86 | $15,480 | $7,079 | 45.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 32 | 32 | $4,160 | $1,804 | 43.4% |
About Dr. Harshadkumar Patel, M.D
Dr. Harshadkumar Patel, M.D is a Psychiatry healthcare provider based in Clearwater, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1952568008.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harshadkumar Patel, M.D has received a total of $5,174 in payments from pharmaceutical and medical device companies, with $1,725 received in 2024. These payments were reported across 267 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,024).
As a Medicare-enrolled provider, Patel has provided services to 1,926 Medicare beneficiaries, totaling 5,818 services with total Medicare billing of $372,441. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Clearwater, FL
- Active Since 05/16/2008
- Last Updated 08/03/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1952568008
Products in Payments
- VRAYLAR (Drug) $862.25
- REXULTI (Drug) $526.42
- AUSTEDO (Drug) $443.08
- INGREZZA (Drug) $350.78
- LATUDA (Drug) $278.14
- ARISTADA (Drug) $257.83
- Austedo XR (Drug) $193.21
- ABILIFY MAINTENA (Drug) $170.57
- CAPLYTA (Drug) $167.32
- Dyanavel XR (Drug) $160.47
- Auvelity (Drug) $137.74
- QELBREE (Drug) $126.45
- QUVIVIQ (Drug) $116.36
- Qelbree (Drug) $99.87
- INVEGA (Drug) $82.11
- UBRELVY (Drug) $81.85
- VYVANSE (Drug) $79.85
- SPRAVATO (Drug) $76.15
- Xelstrym (Drug) $65.48
- JORNAY PM (Drug) $61.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Clearwater
Dr. Michelle Scargle, Md, MD
Psychiatry — Payments: $592,222
Psychiatry $592,222
Dr. Jana Ramsey-Liao, M.d, M.D
Psychiatry — Payments: $22,905
Psychiatry $22,905
Dr. Joseph Shanklin, Md, MD
Psychiatry — Payments: $9,606
Psychiatry $9,606
Joseph Adan, M.d, M.D
Psychiatry — Payments: $6,859
Psychiatry $6,859
Dr. Mariko Brandon, M.d, M.D
Psychiatry — Payments: $4,825
Psychiatry $4,825
Vijay Hegde, M.d, M.D
Psychiatry — Payments: $4,390
Psychiatry $4,390